MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1

Area of Science:

• Molecular Biology
• Hepatology
• Biochemistry

Background:

• Nonalcoholic fatty liver disease (NAFLD) is characterized by increased hepatic lipid droplet and triglyceride (TG) accumulation.
• The precise mechanisms regulating hepatic TG homeostasis are not fully understood.

Purpose of the Study:

• To investigate the role of microRNA-122 (miR-122) in regulating hepatic TG homeostasis.
• To elucidate the molecular mechanisms by which miR-122 influences lipid accumulation.

Main Methods:

• Quantitative PCR and Western blot analyses to assess gene and protein expression.
• Oil red O staining and TG measurements to quantify lipid content.
• Luciferase assay to confirm direct binding of miR-122 to Yin Yang 1 (YY1) mRNA.

Main Results:

• miR-122 was downregulated in hepatocytes and mice with nonalcoholic steatohepatitis (NASH).
• Overexpression of miR-122 inhibited lipid accumulation in vitro and in vivo.
• miR-122 directly targets YY1 mRNA, reducing its stability and consequently upregulating the farnesoid X receptor-small heterodimer partner (FXR-SHP) pathway.

Conclusions:

• miR-122 plays a critical role in regulating hepatic TG accumulation.
• The miR-122/YY1/FXR-SHP axis is a key pathway in maintaining liver lipid homeostasis.